Skip to main content
. Author manuscript; available in PMC: 2014 Feb 13.
Published in final edited form as: Prostate. 2013 Feb 19;73(10):1069–1081. doi: 10.1002/pros.22654

TABLE V.

Effect of αE2 and βE2 on VEGF Gene Expression in Xenograft Tumor Tissues of LAPC-4 or LNCaP Prostate Cancer

Treatment Xenograft LAPC-4
tumor tissue,
VEGF mRNA level
(fold of control)
Xenograft LNCaP
tumor tissue,
VEGF mRNA level
(fold of control)
Placebo 1.00 ± 0.12 (5) 1.00 ± 0.17 (6)
αE2 2 mg 1.13 ± 0.20 (4) 1.34 ± 0.27 (6)
βE2 2 mg 1.18 ± 0.09 (4) 1.07 ± 0.23 (6)

The data are the mean ± SEM and the number in parenthesis indicates the sample size.